We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




New Left-Heart Lead for Cardiac Devices

By HospiMedica staff writers
Posted on 15 May 2002
A left-heart lead that delivers resynchronization therapy for heart failure is designed to offer doctors easier access to the left side of the heart. More...


In resynchronization therapy, an implantable device delivers electrical stimulation to both sides of the heart to optimize the beating action of the lower chambers. Leads connect the implantable device to the chambers of the heart. The new lead, Attain OTW, is intended for use with the InSync and InSync ICD systems developed by Medtronic, Inc. (Minneapolis, MN, USA). The InSync system is an implantable cardiac resynchronization system, while the InSync ICD is intended to sense from the right ventricle only, preventing inappropriate shocks from double counting due to bi-ventricular sensing.
Because each patient's anatomy is unique and heart failure can result in cardiac remodeling, left-heart lead delivery can be difficult, requiring a variety of leads and delivery tools, says Medtronic. Because of its small body size and distal curves designed for ease of steering and mobility, the Attain OTW is designed to allow implanters to maneuver it through small and medium-sized cardiac veins. Medtronic states that it is the only lead of its kind that can be delivered with both a guidewire and a stylet

"The Attain OTW lead lets me choose among more cardiac veins and access them more easily,” said Bruce L. Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at the Cleveland Clinic Foundation (OH, USA). "This allows me to navigate to the left ventricle and place the electrode in the precise position to achieve the best result.”




Related Links:
Medtronic

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Heavy-Duty Wheelchair Scale
6495 Stationary
Premium Air-Mattress
MA-51
Infrared Digital Thermometer
R1B1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.